Interventions for stroke Stroke rates after carotid artery stenting depend on study-specific definitions Staubach S, Soekeland K, Ledwoch J, Segerer M, Strohm H, Mudra H July 20, 2016 | 10.4244/EIJV12I4A88
Coronary interventions Final results of a self-apposing paclitaxel-eluting stent fOr the PErcutaNeous treatment of de novo lesions in native bifurcated coronary arteries study Naber C, Pyxaras S, Nef H, IJsselmuiden A, Briguori C, Schlundt C, Wykrzykowska J, Eberli F, Möllmann H, Galatius S, Rieber J, Commeau P, van Geuns R, Bouchez D, Mudra H June 20, 2016 | 10.4244/EIJY15M06_02
Transcatheter aortic valve implantation (TAVI) by centres with and without an on-site cardiac surgery programme: preliminary experience from the German TAVI registry Eggebrecht H, Mehta R, Haude M, Sack S, Mudra H, Hein R, Brachmann J, Gerckens U, Kuck K, Zahn R, Sechtem U, Richardt G, Schneider S, Senges J September 28, 2014 | 10.4244/EIJV10I5A105
Outcome of patients after emergency conversion from transcatheter aortic valve implantation to surgery Hein R, Abdel-Wahab M, Sievert H, Kuck K, Voehringer M, Hambrecht R, Sack S, Hauptmann K-E, Senges J, Zahn R, Mudra H August 23, 2013 | 10.4244/EIJV9I4A73
Age-related differences in diagnosis, treatment and outcome of acute coronary syndromes: results from the German ALKK registry Rittger H, Hochadel M, Behrens S, Hauptmann K-E, Zahn R, Mudra H, Brachmann J, Senges J, Zeymer U February 21, 2012 | 10.4244/EIJV7I10A191
Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update Cuisset T, Valgimigli M, Mudra H, Muller O, Wijns W, Huber K May 25, 2010
Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions Cuisset T, Mudra H, Muller O, Vogt P, Angelillo-Scherrer A, Huber K August 20, 2008
Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent)™ Duckers H, Soullié T, den Heijer P, Rensing B, de Winter R, Rau M, Mudra H, Silber S, Benit E, Verheye S, Wijns W, Serruys P November 20, 2007
Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent Duckers H, Silber S, de Winter R, den Heijer P, Rensing B, Rau M, Mudra H, Benit E, Verheye S, Wijns W, Serruys P May 22, 2007
The European cobalt STent with Antiproliferative for Restenosis trial (EuroSTAR): 12 month results Dawkins K, Verheye S, Schuhlen H, Dens J, Mudra H, Rutsch W, Stella P, Di Mario C, Thomas M, Serruys P, Colombo A May 22, 2007
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019